(Q84579483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

main subject

metastatic breast cancer

1 reference

1 reference

P. Fedele

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

A. Marino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

L. Orlando

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

P. Schiavone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

A. Nacci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

F. Sponziello

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

P. Rizzo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

N. Calvani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

E. Mazzoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

M. Cinefra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

S. Cinieri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21775129

7 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21775129

7 December 2024

publication date

19 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

8 February 2020

https://api.elsevier.com/content/article/PII:S0959804911004680?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

https://api.elsevier.com/content/article/PII:S0959804911004680?httpAccept=text/plain

7 December 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

European Journal of Cancer

7 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

24-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json

Patient preferences for oral versus intravenous palliative chemotherapy

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Goals of treatment for patients with metastatic breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Optimizing the treatment of metastatic breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer--how low can you go?

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Efficacy of lower dose capecitabine in patients with metastatic breast cancer and factors influencing therapeutic response and outcome.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: a mono-institutional case-series report

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Five years of clinical experience with metronomic chemotherapy: achievements and perspectives

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Chemotherapy for metastatic breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2011.06.040

7 December 2024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775129%20AND%20SRC:MED&resulttype=core&format=json